Most read article(s)

Views & Reviews
Targeting B Cells to Modify MS, NMOSD, and MOGADPart 1
Jonas Graf, Jan Mares, Michael Barnett, et al.

December 16, 2020
Article
Association of intrathecal pleocytosis and IgG synthesis with axonal damage in early MS
Sinah Engel, Falk Steffen, Timo Uphaus, et al.

February 04, 2020
Article
Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS
Sinah Engel, Michaela Friedrich, Muthuraman Muthuraman, et al.

July 19, 2019
Article
Is APOE ε4 associated with cognitive performance in early MS?
Sinah Engel, Christiane Graetz, Anke Salmen, et al.

May 01, 2020
Article
Mesenchymal stem cell-derived neural progenitors in progressive MSTwo-year follow-up of a phase I study
Violaine K. Harris, James W. Stark, Sophia Yang, et al.

December 04, 2020
Views and Reviews
Intermediate uveitis associated with MSDiagnosis, clinical features, pathogenic mechanisms, and recommendations for management
Alan Abraham, Lindsay Nicholson, Andrew Dick, et al.

October 30, 2020
Views & Reviews
Targeting B cells to modify MS, NMOSD, and MOGADPart 2
Jonas Graf, Jan Mares, Michael Barnett, et al.

December 16, 2020
Views & Reviews
Is MS affecting the CNS only?Lessons from clinic to myelin pathophysiology
Ellen Oudejans, Antonio Luchicchi, Eva M.M. Strijbis, et al.

November 24, 2020
Article
No evidence for higher risk of cancer in patients with multiple sclerosis taking cladribine
Julia Pakpoor, Giulio Disanto, Daniel R. Altmann, et al.

October 01, 2015
Clinical/Scientific Notes
Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML
Bettina Fischer-Barnicol, Johanna Oechtering, Jens Kuhle, et al.

December 03, 2020

Pages